ENDOMETRIAL

Clinical trials for ENDOMETRIAL explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL trials appear

Sign up with your email to follow new studies for ENDOMETRIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1

New 'Smart Bomb' drug enters human testing for Tough-to-Treat cancers

Disease control Ongoing

This is an early-stage study testing a new experimental drug called SGN-MesoC2 in people with advanced solid tumors that have come back or stopped responding to standard treatments. The main goal is to find a safe dose and see how the body handles the drug. The drug is designed t…

Matched conditions: ENDOMETRIAL

Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

ENDOMETRIAL

Get alerted when new ENDOMETRIAL trials appear

New 'Smart Bomb' drug enters human testing for Tough-to-Treat cancers